Clinical Trials Directory

Trials / Conditions / Familial Adenomatous Polyposis

Familial Adenomatous Polyposis

53 registered clinical trials studyying Familial Adenomatous Polyposis17 currently recruiting.

StatusTrialSponsorPhase
RecruitingAn Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
NCT06557733
National Cancer Institute (NCI)Phase 2
RecruitingTrial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
NCT06641310
University of Michigan Rogel Cancer CenterN/A
RecruitingTesting for Safety and Colorectal Cancer Preventive Effects of ONC201
NCT05630794
National Cancer Institute (NCI)Phase 1
Not Yet RecruitingSafety Study for the Use of Rapamycin in Children With Familial Adenomatous Polyposis
NCT06308445
University Hospital, ToulousePhase 2
RecruitingTen Versus Fifteen Centimeter Pouch in IPAA Surgery
NCT06538402
Odense University HospitalN/A
RecruitingMicrobial and Environmental Factors Associated with Polyps Development in Familial Adenomatous Polyposis (Micr
NCT06614738
Hospices Civils de Lyon
RecruitingInvestigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis
NCT06578637
Abramson Cancer Center at Penn MedicineN/A
RecruitingChemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous Polypos
NCT06545526
Yonsei UniversityPhase 3
RecruitingCold Atmospheric Plasma for the Endoscopic Treatment of Duodenal Polyps in Patients With Familial Adenomatous
NCT06435533
Universitätsklinikum Hamburg-EppendorfN/A
RecruitingEvaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
NCT05552755
Recursion Pharmaceuticals Inc.Phase 1 / Phase 2
CompletedVisualization of the Papilla Through Use of the NuView Device in Patients With FAP
NCT05657145
Vanderbilt University Medical Center
SuspendedTesting Obeticholic Acid for Familial Adenomatous Polyposis
NCT05223036
National Cancer Institute (NCI)Phase 2
UnknownInherited Cancer Early Diagnosis (ICED) Study
NCT06163365
Royal Marsden NHS Foundation Trust
CompletedThe CHAMP-study: The CHemopreventive Effect of Lithium in Familial AdenoMatous Polyposis
NCT05402891
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Phase 2
RecruitingA Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Ha
NCT04678011
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
CompletedReview of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01
NCT04674228
National Cancer Institute (NCI)
UnknownDNA Adductomics for Colorectal Cancer Investigation
NCT04865601
University of Copenhagen
Active Not RecruitingTrial of ERapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance
NCT04230499
Rapamycin Holdings Inc.Phase 2
RecruitingA Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Fami
NCT04677998
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not Yet RecruitingColorectal Adenoma Canceration in FAP
NCT04531930
Changhai Hospital
UnknownAzithromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis
NCT04454151
Tel-Aviv Sourasky Medical CenterPhase 4
UnknownPerfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses
NCT04709445
Charite University, Berlin, GermanyN/A
UnknownNiclosamide for Familial Adenomatous Polyposis
NCT04296851
Yonsei UniversityPhase 2
Active Not RecruitingCryoBalloon Ablation for Treatment of Duodenal Adenomas
NCT03847636
Johns Hopkins UniversityN/A
UnknownObjective Perfusion Rate Assessment by Near-infrared Fluorescence in Ileal Pouch Formation and Ileal-pouch-ana
NCT04695964
Charite University, Berlin, GermanyN/A
UnknownSubjective Near-infrared Fluorescence Guidance in Perfusion Assessment of Ileal Pouch Formation and Ileal-pouc
NCT04695184
Charite University, Berlin, GermanyN/A
Active Not RecruitingEffect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis
NCT03806426
S.L.A. Pharma AGPhase 3
RecruitingDuodenal Polyposis Classification in FAP
NCT07199127
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
CompletedErlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at R
NCT02961374
National Cancer Institute (NCI)Phase 2
RecruitingCold Snare Polypectomy for Duodenal Adenomas in Familial Adenomatous Polyposis
NCT03471403
Western Sydney Local Health District
RecruitingFamilial Investigations of Childhood Cancer Predisposition
NCT03050268
St. Jude Children's Research Hospital
UnknownTurmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous Polyposis.
NCT03061591
Tel-Aviv Sourasky Medical CenterPhase 2
Terminated18F-FES PET/CT in Imaging Patients With Desmoid Tumors
NCT02374931
Vanderbilt-Ingram Cancer CenterEARLY_Phase 1
UnknownSmall Bowel Endoscopic Evaluation in Familial Adenomatous Polyposis (FAP)
NCT02656134
University of Sao Paulo
CompletedPreliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
NCT02198092
University of Pennsylvania
RecruitingIntegrated Cancer Repository for Cancer Research
NCT02012699
University of Nebraska
CompletedTrial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
NCT01483144
Cancer Prevention Pharmaceuticals, Inc.Phase 3
CompletedThe Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Random
NCT01725490
Yonsei UniversityPhase 2
WithdrawnA Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)
NCT01245816
Cancer Prevention Pharmaceuticals, Inc.Phase 3
CompletedCurcumin in Treating Patients With Familial Adenomatous Polyposis
NCT00641147
National Cancer Institute (NCI)Phase 2
CompletedSingle Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease
NCT01656746
Ohio State University Comprehensive Cancer CenterN/A
CompletedPrevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis
NCT00808743
Radboud University Medical CenterPhase 2 / Phase 3
TerminatedEndomicrocancer: Confocal Endomicroscopy in Patients With High Risk of Colorectal Cancer
NCT01052376
Nantes University HospitalN/A
TerminatedBioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
NCT00663819
W.L.Gore & AssociatesN/A
CompletedUse of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
NCT00927485
University of Puerto RicoN/A
CompletedMultimedia Intervention in Patients With Familial Adenomatous Polyposis (FAP)
NCT00525655
M.D. Anderson Cancer CenterN/A
CompletedLyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP)
NCT00770991
The Cleveland ClinicPhase 1
UnknownAdenoma Detection Rate:NBI, AFI, Chromoscopic or Standard Endoscopy
NCT00253812
London North West Healthcare NHS TrustN/A
WithdrawnUse of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients
NCT00248053
Johns Hopkins UniversityPhase 2
CompletedEndoscopic Papillectomy for Ampullary Adenomas
NCT03494543
Azienda USL Reggio Emilia - IRCCS
CompletedMolecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers
NCT00503035
M.D. Anderson Cancer CenterPhase 2
CompletedCelecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous P
NCT00033371
National Cancer Institute (NCI)Phase 2
CompletedIs Diverting Ileostomy Necessary in Stapled Ileoanal Pouch?
NCT01173250
Mansoura UniversityN/A